- Home
- BST vs TXG Comparison
BST vs TXG Comparison
Compare BST & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BST
- TXG
- Stock Information
- Founded
- BST 2014
- TXG 2012
- Country
- BST United States
- TXG United States
- Employees
- BST N/A
- TXG N/A
- Industry
- BST Finance Companies
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- BST Finance
- TXG Industrials
- Exchange
- BST Nasdaq
- TXG Nasdaq
- Market Cap
- BST 1.5B
- TXG 1.6B
- IPO Year
- BST N/A
- TXG 2019
- Fundamental
- Price
- BST $42.20
- TXG $13.76
- Analyst Decision
- BST
- TXG Buy
- Analyst Count
- BST 0
- TXG 12
- Target Price
- BST N/A
- TXG $13.54
- AVG Volume (30 Days)
- BST 92.9K
- TXG 2.9M
- Earning Date
- BST 01-01-0001
- TXG 11-06-2025
- Dividend Yield
- BST 7.21%
- TXG N/A
- EPS Growth
- BST N/A
- TXG N/A
- EPS
- BST N/A
- TXG N/A
- Revenue
- BST N/A
- TXG $644,466,000.00
- Revenue This Year
- BST N/A
- TXG $2.07
- Revenue Next Year
- BST N/A
- TXG N/A
- P/E Ratio
- BST N/A
- TXG N/A
- Revenue Growth
- BST N/A
- TXG 2.02
- 52 Week Low
- BST $27.87
- TXG $6.78
- 52 Week High
- BST $42.78
- TXG $18.21
- Technical
- Relative Strength Index (RSI)
- BST 62.99
- TXG 60.43
- Support Level
- BST $41.00
- TXG $12.08
- Resistance Level
- BST $41.80
- TXG $13.45
- Average True Range (ATR)
- BST 0.65
- TXG 0.74
- MACD
- BST -0.06
- TXG 0.23
- Stochastic Oscillator
- BST 69.94
- TXG 94.95
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).